Fatty liver disease
The worldwide increase in obesity and diabetes has led to a spike in non-alcoholic fatty liver disease, which often progresses to the more severe condition non-alcoholic steatohepatitis. This Outlook discusses topics such as the surge in drug development that is poised to deliver new treatments; how innovative technologies are enabling earlier diagnosis; and the disturbing rise of fatty liver disease in children.
This Nature Outlook is editorially independent. It is produced with third party financial support. About this content.
Fighting fatty livers
Most of us know the liver as the organ that breaks down alcohol, but it’s actually non-alcoholic fatty liver disease (NAFLD) that has doctors and scientists worried: 1 in 4 people are now affected by this fatty-liver condition. Fatty livers are reversible with changes to diet and exercise. But without intervention, the condition may worsen, becoming known as NASH. This animation explores the ways in which researchers are working to improve diagnosis and treatment of this increasingly common disease.
Fighting fatty livers is an editorially independent animation produced by Nature Video with the financial support from a third party. About this content.
